The Hepatitis C Virus Genotype 2 subtype 2c (HCV-2c) is detected as a low prevalence subtype in many countries, except in Southern Europe and Western Africa. The current epidemiology of HCV in Argentina, a low-prevalence country, shows the expected low prevalence for this subtype. However, this subtype is the most prevalent in the central province of Córdoba. Cruz del Eje (CdE), a small rural city of this province, shows a prevalence for HCV infections of 5%, being 90% of the samples classified as HCV-2c. In other locations of Córdoba Province (OLC) with lower prevalence for HCV, HCV-2c was recorded in about 50% of the samples. The phylogenetic analysis of samples from Córdoba Province consistently conformed a monophyletic group with HCV-2c sequences from all the countries where HCV-2c has been sequenced. The phylogeographic analysis showed an overall association between geographical traits and phylogeny, being these associations significant (α = 0.05) for Italy, France, Argentina (places other than Córdoba), Martinique, CdE and OLC. The coalescence analysis for samples from CdE, OLC and France yielded a Time for the Most Common Recent Ancestor of about 140 years, whereas its demographic reconstruction showed a “lag” phase in the viral population until 1880 and then an exponential growth until 1940. These results were also obtained when each geographical area was analyzed separately, suggesting that HCV-2c came into Córdoba province during the migration process, mainly from Europe, which is compatible with the history of Argentina of the early 20th century. This also suggests that the spread of HCV-2c occurred in Europe and South America almost simultaneously, possibly as a result of the advances in medicine technology of the first half of the 20th century.
Citation: Ré VE, Culasso ACA, Mengarelli S, Farías AA, Fay F, Pisano MB, et al. (2011) Phylodynamics of Hepatitis C Virus Subtype 2c in the Province of Córdoba, Argentina. PLoS ONE 6(5): e19471. https://doi.org/10.1371/journal.pone.0019471
Editor: John E. Tavis, Saint Louis University, United States of America
Received: January 20, 2011; Accepted: March 30, 2011; Published: May 18, 2011
Copyright: © 2011 Ré et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This project was supported by grants from: Fundación Roemmers, Secyt-Universidad Nacional de Córdoba (Secyt UNC- 69/08), Agencia Nacional de Promoción Científica Tecnológica (ANPCyT; PICT2008, 1229), Ministerio de Ciencia y Tecnología, Gobierno de la Provincia de Córdoba (MINCyT- Cba 86/09), SIP- Universidad Católica de Córdoba, Universidad de Buenos Aires (SECyT-UBA2008 B037) and Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET; PIP 112-200801-01169). M.B.P. and A.C.A.C. are recipients of CONICET doctoral fellowships. V.E.R. and R.C. are members of the researcher career from CONICET, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Hepatitis C Virus (HCV) is an enveloped single-stranded positive RNA virus  that currently infects 3% of the world's population . In about 80% of infections, it causes a silent chronic hepatic illness that can lead to fibrosis, cirrhosis and hepatocellular carcinoma . It is taxonomically classified into six genotypes (1 to 6) and many subtypes (a, b, c, etc.) based on the phylogenetic analysis of partial genomic sequences (E1/core and NS5B region) . Genotypes 3 and 6 are thought to have a South Eastern Asian origin, whereas genotypes 1, 2 and 4 may have an African origin, being genotype 2 more prevalent in Western Africa . The current cosmopolitan distribution of certain subtypes such as 1a, 1b, 2a, 2b, 2c and 3a is the result of blood transfusions, intravenous drug abuse and invasive medical and surgical procedures that have been common for the last 80 years . However, the mode of transmission in the ancestral endemic regions is still unknown . The role of human migration in the early and recent spread of some HCV subtypes, such as HCV-2c, has been discussed in recent studies on European populations . Moreover, most of the sequences for HCV-2c deposited in Genbank, including the D50409 “BEBE-1” HCV-2c reference sequence , belong to Europe, mainly France and Italy , . However, HCV-2c has been spotted all around the world as a low-prevalence HCV subtype (http://hcv.lanl.gov).
The occurrence of HCV-2c in Argentina has a particular hallmark, since its prevalence has an interesting geographical correlation: a North-to-South gradient of HCV-2c prevalence has been identified in the Province of Córdoba. A genotype survey carried out with a restriction fragment length polymorphism (RFLP) assay showed that 90% of HCV-infected patients (5% of the population) in Cruz del Eje City (North region of Córdoba Province) have HCV-2a/c . In Córdoba City (which is located in the Central region and is the Capital of the Province and the second most populated city of Argentina) and its surrounding locations, 50% of the patients carrying HCV are infected with HCV-2a/c . Since the RFLP assay is carried out in a highly conserved region of the HCV genome, Ré et al.  used additional sequence information (Core region) in a sub-sample of these patients and found that they were infected with HCV-2c.
Materials and Methods
All patients included in this study signed a written informed consent according to local regulations. This work is part of a research project inscribed and approved by the ethics committee of the Health Ministry of the Province of Córdoba.
Samples were obtained from two sources: 49 samples came from an epidemiological survey carried out in 2004 on a representative sample of 1,471 out of 28,166 inhabitants of Cruz del Eje city  and 26 samples came from patients from the general population attending the Virology Service of the “Instituto Dr. J. M. Vanella” from 1999 to 2008, who at the time of the study were living in Córdoba City and other small cities and towns of the province.
RT-PCR and Sequencing
Serum RNA was extracted with TRIzol Reagent (Invitrogen) following the manufacturer's indications. Reverse transcription was carried out with MMLV-RT (Promega) with Random Hexamer Primers using the manufacturer's protocol. Polymerase chain reaction (PCR) for a 367-bp product of the NS5B region was carried out as described elsewhere  using Green Go Taq Reagents (Promega). Nested PCR for a 677-bp fragment in the E1/E2 region was carried using the primers depicted in Table 1. All PCR products were purified and direct-sequenced by an ABI automatic sequencer.
Mean age of patients from both Cruz del Eje city and other locations of Córdoba was estimated with the patients' age in 2004. The difference between means was tested with a non-paired Student's t-test after testing normality of distribution and equality in variances with Graph Pad Prism 4.02 for Windows.
For subsequent analyses, both E2 and NS5B sequences were prepared in several data sets.
Sequences obtained in this study were classified into two data sets according to their geographical origin: CdE (Cruz del Eje city) and OLC (Other Locations of Córdoba): several towns and cities of the Province of Córdoba).
Sequences downloaded from Genbank were used to build other two data sets: the Genotype Reference Dataset, which contained the sequences that represent the panel of Reference HCV genomes in the NCBI Viral Genotyping Tool plus two more partial NS5B sequences belonging to subtype 2i (marked with *): Subtype 1a: AF009606, AF011751, AF271632; Subtype 1b: D90208, AB049088, AF356827, AF139594; Subtype 1c: D14853, AY051292; Subtype 2a: D00944, AF169004, AB047639, AB047641; Subtype 2b: D10988, AF238486, AB030907, AY232730; Subtype 2c: D50409; Subtype 2i: DQ155561, D86530*, L48499*; Subtype 2k: AB031663; Subtype 3a: D17763, D28917, AF046866; Subtype 3b: D49374; Subtype 3k: D63821; Subtype 4a: Y11604; Subtype 5a: Y13184, AF064490; Subtype 6a: Y12083; Subtype 6b: D84262; Subtype 6d: D84263; Subtype 6g: D63822; Subtype 6h: D84265; Subtype 6k: D84264; and the HCV-2c Dataset, which contained sequences that overlapped the NS5B region studied in this work and that were already classified as subtype 2c when they were deposited in Genbank or reported in relevant publications , . This last data set contained sequences from several countries: Lithuania (1), Russia (2), Canada (3), Estonia (3), Martinique (3), Argentina (from places other than Córdoba Province) (5), Germany (6), Italy (11) and France (24). The French sequences were included in another data set, named Fr, used in a coalescent re-analysis for comparative purposes.
All Genbank sequences tagged as region E1–E2 for HCV subtype 2c were discarded since they overlapped the region analyzed only in the amino terminal segment of E2 (hypervariable region 1).
The phylogeny of the sequences was constructed using the Maximum Likelihood, Neighbor Joining and Parsimony methods.
The Maximum Likelihood tree was constructed with the PhyML 3.0 software  using nonparametric bootstrapping for branch support (100 pseudo replica). The model of nucleotide substitution was selected according to the Akaike Information Criterion implemented in ModelTest 3.7 software  for each data set analyzed.
Neighbor Joining trees were constructed with MEGA 4 Software  setting Maximum Composite Likelihood (Tamura & Nei 1993 substitution model with co-estimation of rate parameters) as the model of nucleotide substitution with heterogeneous rate among sites using the gamma distribution for the relative rate with the alpha shape parameter set according to ModelTest 3.7 estimation. Branch support was assessed by bootstrap analysis over 1000 pseudo replica.
Most parsimonious trees found with TNT software  using a New Technology Search (combining Sectorial Search, Tree Drifting and Tree Fusing) were used to construct a strict consensus tree.
Dating of Most Recent Common Ancestor (tMRCA) of sequences was carried out for NS5B data sets by Monte Carlo Markov Chains (MCMC) Bayesian coalescent analysis implemented in BEAST version 1.6.0 software . All BEAST chains were run for 5×107 generations in order to achieve an Effective Sample Size (ESS)>200. The model of nucleotide substitution was set according to ModelTest results (see “Phylogenetic Analyses”). Since the time interval covered by the sequences of HCV-2c for the NS5B region with known sampling date is about 10 years, the substitution rate parameter could not be reliably estimated, and thus an external substitution rate was used. A substitution rate of 5×10−4 (Standard Deviation = 9×10−5) substitutions per site per year (s/s/y) was set according to a previous estimation  for the NS5B region. Bayesian Skyline Plots (BSPs) were run under the two molecular clock models: Strict and Relaxed Uncorrelated Lognormal. The resulting BSPs were compared by Bayes Factors  and the best clock model was selected for the estimation of tMRCA.
The E2 region substitution rate was also estimated by MCMC analysis. In this case, the tMRCA calculated for the NS5B region was set as prior for the BSP analyses of the E2 data sets. These BSPs were run under the two above-mentioned molecular clock models. Once again, the best clock model was selected by Bayes Factor. Finally, the substitution rate was estimated from the selected BSPs.
All BEAST run logs were analyzed with TRACER program version 1.5 (Available from http://beast.bio.ed.ac.uk/Tracer) after discarding 2% of the run length as burn-in.
The association between phylogeny and geography was statistically assessed in a Bayesian framework implemented in the BaTS program , which takes into account the phylogenetic uncertainty in the analysis. A new data set containing all the sequences of the CdE, OLC and HCV-2c data sets was analyzed with BEAST using BSP as demographic model. Eleven states were defined, named after the origin of the sample: Lithuania, Russia, Canada, Estonia, Martinique, Argentina (places other than Córdoba province), Germany, Italy, France, Cruz del Eje and Other Locations of Córdoba. Two BSPs were run under the different clock models (Strict Clock and Relaxed Uncorrelated Lognormal) and then Bayes Factor was used to select which fitted the data better. The trees obtained with the best clock model were analyzed with BaTS in order to calculate the Parsimony Score (PS), the Association Index (AI) (for overall association) and the Monophyletic Clade (MC) (for each state) statistics. The expected value of the indexes under the non-association hypothesis was estimated by 100 randomized sets.
A total of 75 sera from HCV-infected patients were analyzed. Forty-nine NS5B sequences were obtained for patients from CdE and 26 for patients from OLC. The number of infected patients from CdE increased with age, with a mean age ± S.E.M. of 66.15±1.52 years. Only a few cases (4 out of 49) were detected in patients under 50 years old, whereas 12 infected patients were detected in the 50–60-year old group and other 12 in the 60–70-year old group. Finally, 21 infected patients were either 70 years old or older. In contrast, 18 out of the 26 patients from OLC were aged between 40 and 60 years old. In OLC, the mean age of infected patients was 49.77±2.15.
The difference between means (16.38±2.64 years) was statistically significant, with a p<0.0001 (Student t-test). Both populations passed the D'Agostino & Pearson Normality Test and their variances were not significantly different (Table 2).
Genbank Accession Numbers
The sequences obtained in this study were deposited in the Genbank under the following accession numbers: JF511020 to JF511061 for the E1/E2 region and JF511062 to JF511136 for the NS5B region.
Phylogenetic analyses were performed using sequences from the NS5B and E2 regions with the Maximum Likelihood, Neighbor Joining and Parsimony methods.
The analyses were carried out using NSB5 sequences in a combined data set which contained the data sets from CdE (49 sequences)+OLC (26 sequences)+HCV-2c (61 sequences)+Genotype Reference (36 sequences). The Maximum Likelihood phylogenetic reconstruction of these sequences (Figure 1) showed well-supported groups for each genotype and for subtype 2a (bootstrap value of 87). Subtypes 2b and 2i also formed clusters, although poorly supported. The CdE, OLC and HCV-2c sequences clustered with the HCV-2c reference sequence, forming a monophyletic group. When analyzed by the Neighbor Joining and Parsimony methods, the tree topology obtained for the same data set was similar to that obtained by Maximum Likelihood. In the case of the tree obtained by Neighbor Joining, the subtypes had higher bootstrap values and the HCV-2c cluster was supported with a value of 86 (Figure S1). The parsimony analysis yielded 56 most parsimonious trees with a total length of 2407 steps. These trees were used to construct a strict consensus tree which also showed clear subtype clustering and grouped all the sequences from the Province of Córdoba with those already genotyped as HCV-2c in a monophyletic (but collapsed) cluster (Figure S2).
Black bullets: Sequences from the Genotype Reference dataset; Hollow bullets: Sequences from the HCV-2c dataset. Light gray bullets: Sequences from the CdE data set. Dark gray bullets: Sequences from the OLC data set, Numbers above branches: bootstrap values over 100 pseudoreplica. Scale bar represents substitution per site.
The E2 region was analyzed with a combined data set containing the data sets from CdE (27 sequences)+OLC (15 sequences)+Genotype Reference (34 sequences), yielding results similar to those obtained for the NS5B region, although higher bootstrap values in the E2 phylogeny and better support of the subtype clusters were observed (Figure S3). Geographical association could not be assessed for this region since the only HCV-2c E2 sequence spanning the region analyzed outside the Province of Córdoba belonged to the Genotype Reference data set.
The relaxed uncorrelated lognormal clock model was selected by analyzing the Bayes factor of BSPs. The overall association between geographic traits and phylogeny was assessed by AI and PS (Table 3). Both indexes showed statistically significant (p<0.001) differences with the null distribution (i.e., no association). Interestingly, the state-specific index MC showed a significant (p<0.05) association for Italy, Argentina (places other than Córdoba Province), France, Martinique, Other Locations of Córdoba Province and Cruz del Eje.
The estimation of tMRCA was carried out by coalescent analysis of the following NS5B data sets and combinations: 1) CdE; 2) OLC; 3) Fr; 4) CdE+OLC; 5) CdE+OLC+Fr.
For all data sets, the relaxed clock model performed better than the strict one by analyzing the Bayes factor of BSPs. The tMRCA (expressed in years before last sampling date) for the analyses were between 107 y (OLC data set) and 138 y (CdE+OLC+Fr combined data set) (Table 4).
In addition, the skyline plot profiles for all the data sets analyzed, except for the OLC one, were in a steady non-expanding “lag” phase up to about 1880, then grew exponentially up to the 1940s, and finally were again in a lag phase after the 1960s (Figure 2 A, B and D). The OLC BSP showed little expansion of the population size since the tMRCA up to the 1940s, then the population remained constant until the 1980s and finally it seems to be declining until the present time (Figure 2 C).
X axis: Date in Years A. C.; Y axis: Estimated effective number of infections; Bold Dashed Line: Median time of most recent common ancestor (tMRCAtMCRA); Light Dashed Line: Upper HPD95% of tMRCA. Bold Line: Mean Effective Number of viral population. Blue Lines: Upper and Lower HPD95% of Effective Number of viral population. Analyzed data sets: A. CdE+OLC: Samples from Cruz del Eje and Other locations of Córdoba Province; B. CdE: Samples from Cruz del Eje; C. OLC: Samples from other locations of Córdoba Province; D. FR: Samples from South Western France (Cantaloube et al., 2008).
The substitution rate was also estimated by coalescent analysis of the following E2 data sets and combinations: 1) CdE; 2) OLC; 3) CdE+OLC.
For each data set, the tMRCA was set as a prior with gamma distribution, where the shape and the scale parameters were set according to the distribution of the previously estimated tMRCA of the corresponding NS5B data set. Since there are samples with sequences only for the NS5B region, the tMRCA was re-estimated using reduced data sets containing only NS5B sequences that had its E2 counterparts. It is not surprising that tMRCA estimation with the full and the reduced data sets was almost the same (Data S1 (Raw_TMRCA_estimation.xls)).The tMRCA gamma prior set for each data set, described by its median (5% and 95% percentiles) in years before present were: 106.9 (67.0 to 152.5) for the CdE data set, 108.9 (71.2 to 158.0) for the OLC data set and 131.1 (86.4 to 189.2) for the CdE+OLC data set. The estimated substitution rates for the E2 region (expressed in s/s/y, high posterior probability density 95% in parentheses) were: 1.14×10−3 (0.63×10−3 to 1.83×10−3) for the CdE data set, 1.77×10−3 (0.96×10−3 to 2.96×10−3) for the OLC data set and 1.87×10−3 (1.02×10−3 to 3.11×10−3) for the CdE+OLC data set (Table 5). The skyline profiles of the CdE, OLC and CdE+OLC data sets were compatible with those obtained by the NS5B region. They showed a lag phase until 1900 followed by exponential growth until 1950–1960 and then again a constant population size until the present (Figure S4).
It has been proposed that HCV Genotype 2 may have originated in Western Africa . The role of human migration in the early and recent spread of some HCV subtypes, such as HCV-2c, has been evidenced in recent works in European populations . Although most HCV-2c sequences deposited in Genbank were obtained from samples from Europe, mainly France and Italy , , this may not reflect t a possible European origin of the sequences, but rather that these countries have carried out more detailed epidemiological studies. Interestingly, certain subtypes like 2a, 2b and 2c have a worldwide distribution, possibly associated with a relatively recent dissemination through blood transfusions, surgical practices and intravenous drug abuse. However, in some countries, such as Italy, HCV-2c is an epidemiological important subtype, being the second most prevalent (after HCV-1b) with the particularity that it forms an increasing north-to-south gradient of prevalence and it is associated with elder patients . In Cruz del Eje city, HCV-2c accounts for 90% of HCV infections, whereas in other cities and towns of the Province of Córdoba it accounts for 50% , . The fact that 21 out of the 49 sequenced samples from Cruz del Eje belong to patients older than 70 years, as that observed in Italy, suggests that the spread of HCV in the population was a past event. A different situation was observed in other towns and cities of the Province of Córdoba (including Córdoba city), where most of the infected patients were between 40 and 50 years old (in 2004), which suggests that the dissemination occurred more recently.
In order to trace back the origin and dissemination of HCV-2c in the Province of Córdoba, phylogenetic analysis was performed using the Maximum Likelihood, Parsimony and Neighbor Joining methods. In all cases, the sequences from Córdoba consistently formed a monophyletic group with the sequences from all the countries where HCV-2c has been sequenced. A similar analysis was carried out with the E2 region and, again, the samples from Córdoba also grouped with the HCV-2c reference genomes.
The demographic history was estimated by coalescent analysis of NS5B sequences. The Bayesian Skyline Plot was set as a demographic model because it allows the reconstruction of the population dynamics without imposing any parametric model . Since the samples from this study represent less than 10 years of history (i.e. the samples are almost contemporaneous), a previously calculated substitution rate of 5×10−4 s/s/y  was used. Unfortunately, the use of an external rate to calibrate the relaxed molecular clock has some drawbacks. One of these drawbacks is that it has to be set as a global rate including all CdE and OLC samples even when these populations have a different patient's age and may have different intra-host evolution time, leading to different substitution rates. This drawback is, to some extent, avoided by using a relaxed molecular clock, which allows the rate to vary among lineages. Another drawback is that it has to be set as a prior distribution (i.e. normal distribution) with a high standard deviation which leads to broad estimation errors (HPD95% limits). Thus, the results have to be taken with care. Under these priors, the data sets analyzed yielded a time for the most recent common ancestor (tMRCA) ranging from 107.8 years for OLC to 138.5 years for CdE+OLC+Fr, but since all HPD95% intervals included the medians of the other data sets, there were no significant differences between the estimated tMRCAs. It is worth noting that when the analyses are carried out using recent re-calculated substitution rates (for exactly the same genomic fragment) between 2.5×10−3 and 4×10−3 s/s/y , , the resulting tMRCAs are about 30 to 40 years. This estimation appears too recent to fit with the epidemiological information such as the fact that 21 out of 49 infected patients are at least 70 years old.
The skyline plot profiles using 5×10−4 s/s/y as substitution rate showed an exponential growth of the effective number of infections for the CdE and Fr data sets for a period of about 60 years (from 1880–1890 to 1940–1950), after which it remained constant. It is worth noting that the upper (HPD95%) limit for population size in the four data sets remained constantly high, making these BSPs compatible with a constant size population dynamics. However, the changes in the viral population depicted in the NS5B BSP profiles were further supported when the E1/E2 region was analyzed. In this case, the profile obtained was very similar to the corresponding NS5B data set but with narrower HPD95% intervals. Moreover, this hypothesis is supported by the fact that the Argentinean population experienced an important growth (due to immigration) in the period of the exponential growth shown by the skyline. Such a change in the host density is usually associated with the emergence of viral infections .
When the BSP analysis was carried out using substitution rates of 2.5×10−3 or 4×10−3 s/s/y, a similar demographic profile was obtained, although with an exponential period of around 10 years between 1985 and 1995, which again does not fit with the epidemiological information. The results of both tMRCA and BSP analyses highlight the influence of prior selection in the coalescent analysis and encourage the research aimed to obtain a more accurate estimation of the substitution rate.
The global dispersal of HCV and that of several other pathogens show a similar demographic pattern, which may be the consequence of a process associated with blood transfusions, intravenous drug abuse and invasive medical and surgical procedures that have been common during the last 80 years .
It has been reported that global dispersal of HCV-1b and HCV-1a has occurred by these means. Moreover, in the case of HCV-1b, the spread of the virus has occurred in a two-step process, first in developed countries, and then in developing countries . In Argentina, which is a developing country, the previously estimated tMRCA for HCV-1b in the cosmopolitan city of Buenos Aires (∼50 years)  and in the small town of Wheelwright (∼55 years)  were more recent than the tMRCA estimated for HCV-2c.
The phylogeographic analysis showed that samples from CdE, OLC, Italy, France, Argentina and Martinique grouped non-randomly according to their geographical origin, which suggests that the emergence and diversification of these sequences is probably a recent event from ancestral sequences located in each geographical region. A more representative sampling would be required to make further speculations about the global path of HCV-2c transmission.
The history of Argentina shows immigration from regions where HCV-2c is an epidemiological important subtype: Africa and Europe. Although during the 16th–18th centuries Argentina received immigrants from Africa as slaves, the present ethnic composition of the population was strongly affected by the European immigration process (mainly from Italy) occurred during the first half of the 20th century (particularly between 1880 and 1920). The settlement of the Italian immigrants in the central region of Argentina, where the Province of Córdoba is located, was rural. This can account for the current distribution of HCV-2c with higher prevalence and patient's age in the “rural” city of Cruz del Eje, compared with the “cosmopolitan” city of Córdoba.
In summary, the origin of HCV-2c circulating in Argentina may be related to the European immigration. The lack of HCV-2 subtypes other than 2c and the presence of HCV-1b, together with the similar distribution in the age of infected patients and the migration history of Argentina, suggest that Italy might be the source of the HCV-2c circulating in Córdoba. Finally, these results suggest that HCV-2c simultaneously suffered an emerging process, perhaps associated with those medical care factors mentioned above (i.e. blood transfusions, injectable treatments, etc.).
The study of the genetic diversity of HCV circulating in different countries and regions not only provides useful information for the local epidemiology and diagnosis but also serves as another piece on the puzzle of HCV evolution.
Neighbor Joining Tree for the NS5B region. The nucleotide substitutions process was modeled with Maximum Composite Likelihood (TrN93) model (MEGA4 software). Black bullets: Sequences from the Genotype Reference dataset; Hollow bullets: Sequences from the HCV-2c dataset. Light gray bullets: Sequences from the CdE data set. Dark gray bullets: Sequences from the OLC data set, Numbers above branches: bootstrap values over 1000 pseudoreplica. Scale bar represents substitution per site.
Strict Consensus tree constructed using the 56 most parsimonious trees (2407 steps) found using the New Technology Search (TNT software) for the NS5B region. Black bullets: Sequences from the Genotype Reference dataset; Hollow bullets: Sequences from the HCV-2c dataset. Light gray bullets: Sequences from the CdE dataset. Dark gray bullets: Sequences from the OCL dataset, Numbers above branches: bootstrap values over 100 pseudoreplica. Scale bar represents substitution per site.
Maximum likelihood tree for the E2 region constructed using GTR+Γ+I as model of nucleotide substitution with parameters suggested by ModelTest 3.7 (PhyML software). Black bullets: Sequences from the Genotype Reference dataset; Light gray bullets: Sequences from the CdE data set. Dark gray bullets: Sequences from the OLC data set, Numbers above branches: bootstrap values over 100 pseudoreplica. Scale bar represents substitution per site.
Bayesian Skyline Plots for Demographic Reconstruction using E1E2 sequences. X axis: Date in Years A. C.; Y axis: Estimated effective number of infections; Bold Dashed Line: Median time of most recent common ancestor (tMRCA); Light Dashed Line: Upper HPD95% of tMRCA. Bold Line: Mean Effective Number of viral population. Blue Lines: Upper and Lower HPD95% of Effective Number of viral population. Analyzed data sets: A. CdE: Samples from Cruz del Eje; B. OLC: Samples from other locations of Córdoba Province; C. CdE+OLC: Samples from Cruz del Eje and Other locations of Córdoba Province.
Conceived and designed the experiments: ACAC VER RHC. Performed the experiments: VER ACAC MBP AAF. Analyzed the data: ACAC VER. Contributed reagents/materials/analysis tools: SM FF OE MSC. Wrote the paper: VER ACAC RHC.
- 1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, et al. (1989) Isolation of a cDNA clone derived from a blood-borne non A non B viral hepatitis genome. Science 244: 359–362.QL ChooG. KuoAJ WeinerLR OverbyDW Bradley1989Isolation of a cDNA clone derived from a blood-borne non A non B viral hepatitis genome.Science244359362
- 2. Lavanchi D (2009) The Global Burden of Hepatitis C. Liver Int 29(s1): 74–81.D. Lavanchi2009The Global Burden of Hepatitis C.Liver Int29s17481
- 3. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41–52.GM LauerBD Walker2001Hepatitis C virus infection.N Engl J Med3454152
- 4. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, et al. (2005) Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes. Hepatology 42: 962–973.P. SimmondsJ. BukhC. CombetG. DeléageN. Enomoto2005Consensus Proposals for a Unified System of Nomenclature of Hepatitis C Virus Genotypes.Hepatology42962973
- 5. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus–15 years on. J Gen Virol 85(Pt 11): 3173–88.P. Simmonds2004Genetic diversity and evolution of hepatitis C virus–15 years on.J Gen Virol85Pt 11317388
- 6. Cantaloube JF, Gallian P, Laperche S, Elghouzzi MH, Piquet Y, et al. (2008) Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors. J Med Virol 80(10): 1732–9.JF CantaloubeP. GallianS. LapercheMH ElghouzziY. Piquet2008Molecular characterization of genotype 2 and 4 hepatitis C virus isolates in French blood donors.J Med Virol801017329
- 7. Nakao H, Okamoto H, Tokita H, Inoue T, Iizuka H, et al. (1996) Full-length genomic sequence of a hepatitis C virus genotype 2c isolate (BEBE1) and the 2c-specific PCR primers. Arch Virol 141(3–4): 701–704.H. NakaoH. OkamotoH. TokitaT. InoueH. Iizuka1996Full-length genomic sequence of a hepatitis C virus genotype 2c isolate (BEBE1) and the 2c-specific PCR primers.Arch Virol1413–4701704
- 8. Thomas F, Nicot F, Sandres-Sauné K, Dubois M, Legrand-Abravanel F, et al. (2007) Genetic diversity of HCV genotype 2 strains in south western France. J Med Virol 79(1): 26–34.F. ThomasF. NicotK. Sandres-SaunéM. DuboisF. Legrand-Abravanel2007Genetic diversity of HCV genotype 2 strains in south western France.J Med Virol7912634
- 9. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, et al. (2005) Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76(3): 327–332.F. AnsaldiB. BruzzoneS. SalmasoMC RotaP. Durando2005Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy.J Med Virol763327332
- 10. Mengarelli S, Correa G, Farias A, Juri M, Cudola A, et al. (2006) ¿Por qué el virus de la Hepatitis C en Cruz del Eje?. Acta Gastroenterol Latinoam 36(S.3): S 68.S. MengarelliG. CorreaA. FariasM. JuriA. Cudola2006¿Por qué el virus de la Hepatitis C en Cruz del Eje?.Acta Gastroenterol Latinoam36S.3S 68
- 11. Ré V, Lampre E, Yoshida CF, Mendes de Oliveira J, Lewis-Ximenez L, et al. (2003) Hepatitis C virus genotypes in Cordoba, Argentina. Unexpected high prevalence of genotype 2. Medicina (B Aires) 63(3): 205–210.V. RéE. LampreCF YoshidaJ. Mendes de OliveiraL. Lewis-Ximenez2003Hepatitis C virus genotypes in Cordoba, Argentina. Unexpected high prevalence of genotype 2.Medicina (B Aires)633205210
- 12. Ré V, Contigiani M, Fumiko C, Yoshida T, Lampe E (2007) Identification of hepatitis C virus subtype 2c by sequencing analysis in patients from Córdoba, Argentina. Mem Inst Oswaldo Cruz 102(8): 995–998.V. RéM. ContigianiC. FumikoT. YoshidaE. Lampe2007Identification of hepatitis C virus subtype 2c by sequencing analysis in patients from Córdoba, Argentina.Mem Inst Oswaldo Cruz1028995998
- 13. Chen Z, Weck KE (2002) Hepatitis C virus genotyping: interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b. J Clin Microbiol 40(9): 3127–34.Z. ChenKE Weck2002Hepatitis C virus genotyping: interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and 1b.J Clin Microbiol409312734
- 14. Quarleri JF, Robertson BH, Mathet VL, Feld M, Espínola L, et al. (2000) Genomic and phylogenetic analysis of hepatitis C virus isolates from argentine patients: a six-year retrospective study. J Clin Microbiol 38(12): 4560–4568.JF QuarleriBH RobertsonVL MathetM. FeldL. Espínola2000Genomic and phylogenetic analysis of hepatitis C virus isolates from argentine patients: a six-year retrospective study.J Clin Microbiol381245604568
- 15. Dal Molin G, Ansaldi F, Biagi C, D'Agaro P, Comar M, et al. (2002) Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. J Med Virol 68(3): 352–6.G. Dal MolinF. AnsaldiC. BiagiP. D'AgaroM. Comar2002Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.J Med Virol6833526
- 16. Guindon S, Gascuel O (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52(5): 696–704.S. GuindonO. Gascuel2003A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.Syst Biol525696704
- 17. Posada D, Crandall KA (1998) Modeltest: testing the model of DNA substitution. Bioinformatics 14(9): 817–818.D. PosadaKA Crandall1998Modeltest: testing the model of DNA substitution.Bioinformatics149817818
- 18. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596–1599.K. TamuraJ. DudleyM. NeiS. Kumar2007MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.Mol Biol Evol2415961599
- 19. Goloboff PA, Farris JS, Nixon KC (2008) TNT, a free program for phylogenetic analysis. Cladistics 24(5): 774–786.PA GoloboffJS FarrisKC Nixon2008TNT, a free program for phylogenetic analysis.Cladistics245774786
- 20. Drummond AJ, Rambaut A (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214.AJ DrummondA. Rambaut2007BEAST: Bayesian evolutionary analysis by sampling trees.BMC Evol Biol7214
- 21. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, et al. (2001) The Epidemic Behavior of the Hepatitis C Virus. Science 292: 2323–2325.OG PybusMA CharlestonS. GuptaA. RambautEC Holmes2001The Epidemic Behavior of the Hepatitis C Virus.Science29223232325
- 22. Suchard MA, Weiss RE, Sinsheimer JS (2001) Bayesian selection of continuous-time Markov chain evolutionary models. Mol Biol Evol 18(6): 1001–1013.MA SuchardRE WeissJS Sinsheimer2001Bayesian selection of continuous-time Markov chain evolutionary models.Mol Biol Evol18610011013
- 23. Parker J, Rambaut A, Pybus OG (2008) Correlating viral phenotypes with phylogeny: accounting for phylogenetic uncertainty. Infection, Genetics and Evolution 8(3): 239–246.J. ParkerA. RambautOG Pybus2008Correlating viral phenotypes with phylogeny: accounting for phylogenetic uncertainty.Infection, Genetics and Evolution83239246
- 24. Morse SS (1995) Factors in the emergence of infectious diseases. Emerg Infect Dis 1(1): 7–15.SS Morse1995Factors in the emergence of infectious diseases.Emerg Infect Dis11715
- 25. Drummond AJ, Rambaut A, Shapiro B, Pybus OG (2005) Bayesian Coalescent Inference of Past Population Dynamics from Molecular Sequences. Mol Biol Evol 22(5): 1185–1192.AJ DrummondA. RambautB. ShapiroOG Pybus2005Bayesian Coalescent Inference of Past Population Dynamics from Molecular Sequences.Mol Biol Evol22511851192
- 26. Magiorkinis G, Magiorkinis E, Paraskevis D, Ho SY, Shapiro B, et al. (2009) The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 6(12): e1000198.G. MagiorkinisE. MagiorkinisD. ParaskevisSY HoB. Shapiro2009The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis.PLoS Med612e1000198
- 27. Golemba MD, Di Lello FA, Bessone F, Fay F, Benetti S, et al. (2010) High prevalence of hepatitis C virus genotype 1b infection in a small town of Argentina. Phylogenetic and Bayesian coalescent analysis. PLoS One 5(1): e8751.MD GolembaFA Di LelloF. BessoneF. FayS. Benetti2010High prevalence of hepatitis C virus genotype 1b infection in a small town of Argentina. Phylogenetic and Bayesian coalescent analysis.PLoS One51e8751
- 28. Di Lello F, Garcia G, Kott V, Sookoian S, Campos R (2008) Diversity of hepatitis C virus genotype 1b in Buenos Aires, Argentina: description of a new cluster associated with response to treatment. J Med Virol 80(4): 619–627.F. Di LelloG. GarciaV. KottS. SookoianR. Campos2008Diversity of hepatitis C virus genotype 1b in Buenos Aires, Argentina: description of a new cluster associated with response to treatment.J Med Virol804619627